Related Experiment Video
Updated: May 14, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
[Secondary prevention of ischemic stroke in children]
Insights
Pediatric arterial ischemic stroke (IS) is a major cause of childhood disability. This review highlights international guidelines for secondary stroke prevention, emphasizing anticoagulation and antiplatelet therapies.
Area of Science:
- Neurology
- Pediatrics
- Cardiology
Context:
- Pediatric arterial ischemic stroke (AIS) is a significant cause of lifelong disability in children.
- Arteriopathies resulting from trauma and infection are key contributors to childhood AIS.
- Effective secondary stroke prevention requires consideration of underlying pathogenetic mechanisms and vascular risk factors.
Purpose:
- To review recent international clinical recommendations for secondary stroke prevention in pediatric arterial ischemic stroke.
- To analyze the efficacy of anticoagulation and antiplatelet therapies based on multicenter clinical studies.
- To inform the development of Russian standards for secondary AIS prevention.
Summary:
- Current secondary stroke prevention for children primarily involves anticoagulation or antiplatelet treatments.
- International guidelines, particularly from the USA cardiology association, are based on randomized multicenter clinical studies.
- There is limited experience with these therapies in Russia, necessitating the adoption of international standards.
Impact:
- Provides a foundation for establishing evidence-based Russian clinical guidelines for pediatric arterial ischemic stroke.
- Aims to improve long-term outcomes and reduce disability associated with childhood stroke.
- Facilitates the practical application of international best practices in the Russian healthcare system.
Abstract:
Pediatric arterial ischemic stroke (IS) is an important cause of lifelong disability. Arteriopathies due to trauma and infection are an important underlying cause of childhood arterial ischemic stroke. The secondary prevention of IS should be conducted taking into account the main pathogenetic mechanisms and vascular risk factors. For secondary stroke prevention, the majority of children are treated with either anticoagulation or antiplatelet therapies. This review focuses on the recent international clinical recommendations in secondary stroke prevention based on the results of randomized multicenter clinical studies published by the USA. cardiology association. Experience of anticoagulation or antiplatelet therapies for secondary stroke prevention is insufficient in Russia. Taking into account the available international recommendations is expedient for creation and practical application of the Russian standards for secondary arterial ischemic stroke prevention.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Hemorrhagic Stroke l: Introduction